Cargando…

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control

The caregiver perspective on pediatric attention-deficit/hyperactivity disorder (ADHD) study (CAPPA) was a web-based, cross-sectional survey of caregivers of children and adolescents (6–17 years of age) with ADHD and was conducted in 10 European countries. CAPPA included caregiver assessments of glo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridman, Moshe, Banaschewski, Tobias, Sikirica, Vanja, Quintero, Javier, Erder, M Haim, Chen, Kristina S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315351/ https://www.ncbi.nlm.nih.gov/pubmed/28243096 http://dx.doi.org/10.2147/NDT.S121639

Ejemplares similares

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
por: Fridman, Moshe, et al.
Publicado: (2017)

Unmet Needs Associated with Attention-Deficit/Hyperactivity Disorder in Eight European Countries as Reported by Caregivers and Adolescents: Results from Qualitative Research
por: Sikirica, Vanja, et al.
Publicado: (2014)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective
por: Setyawan, Juliana, et al.
Publicado: (2014)

Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder
por: Gajria, Kavita, et al.
Publicado: (2015)

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
por: Sikirica, Vanja, et al.
Publicado: (2012)

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
por: Erder, M. Haim, et al.
Publicado: (2013)

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology
por: Sikirica, Vanja, et al.
Publicado: (2013)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

Color naming deficits and attention-deficit/hyperactivity disorder: A retinal dopaminergic hypothesis
por: Tannock, Rosemary, et al.
Publicado: (2006)

Molecular genetics of attention-deficit/hyperactivity disorder: an overview
por: Banaschewski, Tobias, et al.
Publicado: (2010)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument
por: Hareendran, Asha, et al.
Publicado: (2015)

Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
por: Sikirica, Vanja, et al.
Publicado: (2017)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014)

Interpreting the Results of a Retrospective Comparison of Test and Reference Treatments in a Randomized Clinical Trial Setting
por: Fridman, Moshe, et al.
Publicado: (2014)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system
por: Young, Susan, et al.
Publicado: (2018)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison
por: Joseph, Alain, et al.
Publicado: (2017)

Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury
por: Young, Susan, et al.
Publicado: (2018)

Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
por: Greven, Peter, et al.
Publicado: (2016)

Twin and Sibling Studies Using Health Insurance Data: The Example of Attention Deficit/Hyperactivity Disorder (ADHD)
por: Langner, Ingo, et al.
Publicado: (2013)

Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial
por: Stein, Mark A., et al.
Publicado: (2015)

Differential utility of teacher and parent–teacher combined information in the assessment of Attention Deficit/Hyperactivity Disorder symptoms
por: Garcia-Rosales, Alexandra, et al.
Publicado: (2020)

MEG Analysis of Neural Interactions in Attention-Deficit/Hyperactivity Disorder
por: Khadmaoui, Amine, et al.
Publicado: (2016)

Attention-Deficit/Hyperactivity Disorder Remission Is Linked to Better Neurophysiological Error Detection and Attention-Vigilance Processes
por: Michelini, Giorgia, et al.
Publicado: (2016)

Association of Preterm Birth With Attention-Deficit/Hyperactivity Disorder–Like and Wider-Ranging Neurophysiological Impairments of Attention and Inhibition
por: Rommel, Anna-Sophie, et al.
Publicado: (2017)

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
por: Banaschewski, Tobias, et al.
Publicado: (2018)

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder
por: Coghill, David R, et al.
Publicado: (2020)

Associations between symptoms of attention-deficit/ hyperactivity disorder and life satisfaction in medical students: the mediating effect of resilience
por: Shi, Meng, et al.
Publicado: (2018)

Underdiagnosis of Attention-Deficit/Hyperactivity Disorder in Adult Patients: A Review of the Literature
por: Ginsberg, Ylva, et al.
Publicado: (2014)

A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations
por: Young, S., et al.
Publicado: (2015)

Attention-Deficit/Hyperactivity Disorder and Martial Satisfaction: The Preliminary Roles of Employment and Income
por: Kachooei, Hamid, et al.
Publicado: (2016)

Identifying potentially marker symptoms of attention-deficit/hyperactivity disorder
por: Arias, Víctor B., et al.
Publicado: (2018)

Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia
por: Arican, I., et al.
Publicado: (2018)

Attention‐deficit hyperactivity symptoms and risk of alcohol use relapse
por: Kawata, Takahiro, et al.
Publicado: (2022)

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_tse988o320220jrcuh9i1e6fr9